Single-agent paclitaxel in advanced anal cancer after failure of cisplatin and 5-fluorouracil chemotherapy

Anticancer Research

Volumn 31, Issue 12, 2011, Pages 4637-4640

  Abbas, Ali ^a   Nehme, Elie ^a   Fakih, Marwan ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

5 FU; Anal cancer; Cisplatin; Paclitaxel

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN C; PACLITAXEL;

ABSENCE OF SIDE EFFECTS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ADVANCED CANCER; AFRICAN AMERICAN; ALCOHOLISM; ANUS CANCER; ANUS INTERCOURSE; ARTICLE; BACKACHE; BONE METABOLISM; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RESISTANCE; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONDYLOMA; DISEASE COURSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPICE CARE; HUMAN; ILIAC BONE; LEUKOENCEPHALOPATHY; LIVER METASTASIS; LUNG METASTASIS; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; NEUROPATHY; PALLIATIVE THERAPY; PELVIS LYMPH NODE; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RECURRENT CANCER; SALVAGE THERAPY; SMOKING; SPINE METASTASIS; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; UNSPECIFIED SIDE EFFECT; VERRUCA VULGARIS;

ADULT; ANTINEOPLASTIC AGENTS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; MALE; MICROTUBULES; MIDDLE AGED; NEOPLASM METASTASIS; PACLITAXEL; TREATMENT OUTCOME;

EID: 84855167499     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA: a cancer journal for clinicians 61: 69-90, 2011.
2. Hurwitz H, Fehrenbacher L, Cartwright T, Hainsworth J, Heim W, Berlin J, Kabbinavar F, Novotny W and Scappaticci F: Wound healing/bleeding in metastatic colorectal cancer patients who undergo surgery during treatment with bevacizumab.
3. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M and Pierart M: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15: 2040-2049, 1997. (Pubitemid 27209535)
4. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 348: 1049-1054, 1996.
5. James R, Wan S, Glynne-Jones R, Sebag-Montefiore D, Kadalayil L, Northover J, Cunningham D, Meadows H and Ledermann J: A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). J Clin Oncol (Meeting Abstracts) 27: LBA4009, 2009.
6. Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA and Willett C: Fluorouracil, mitomycin, and radiotherapy vs. fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. Jama 299: 1914-1921, 2008. (Pubitemid 351574921)
7. Ajani JA, Carrasco CH, Jackson DE and Wallace S: Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med 87: 221-224, 1989. (Pubitemid 19201647)
8. Faivre C, Rougier P, Ducreux M, Mitry E, Lusinchi A, Lasser P, Elias D and Eschwege F: 5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer. Bull Cancer 86: 861-865, 1999.
9. Engstrom PF, Amoletti JP, Benson AB 3rd, Berlin JD, Berry JM, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Knol JA, Leong LA, Lin E, Mulcahy MF, Rohren E, Ryan DP, Saltz L, Shibata D, Skibber JM, Small W, Sofocleous C, Thomas J, Venook AP and Willett C: NCCN clinical practice guidelines in oncology. Anal carcinoma. J Natl Compr Canc Netw 8: 106-120, 2010.
10. Kudelka AP, Winn R, Edwards CL, Downey G, Greenberg H, Dakhil SR, Freedman RS, Loyer E, Rusinkiewicz J, Gacrama P, Fueger R and Kavanagh JJ: Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Clin Cancer Res 2: 1285-1288, 1996. (Pubitemid 26299425)
11. Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, Miller DS, Oh G, King S, Boggess JF and Rocereto TF: Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study. J Clin Oncol 22: 3113-3119, 2004. (Pubitemid 41103724)
12. Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L and Cortés-Funes H: Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer. J Clin Oncol 23: 8636-8645, 2005. (Pubitemid 46211506)
13. Forastiere AA, Leong T, Rowinsky E, Murphy BA, Vlock DR, DeConti RC and Adams GL: Phase III Comparison of High-Dose Paclitaxel + Cisplatin + Granulocyte Colony-Stimulating Factor Versus Low-Dose Paclitaxel + Cisplatin in Advanced Head and Neck Cancer: Eastern Cooperative Oncology Group Study E1393. J Clin Oncol 19: 1088-1095, 2001. (Pubitemid 32176285)
14. Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J and Forastiere AA: Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group. J Clin Oncol 23: 3562-3567, 2005.
15. Forastiere AA, Shank D, Neuberg D, Taylor SGt, DeConti RC and Adams G: Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390). Cancer 82: 2270-2274, 1998. (Pubitemid 28240836)
16. McGuire W, Blessing J, Moore D, Lentz S and Photopulos G: Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol 14: 792-795, 1996. (Pubitemid 26085522)
17. Rose PG, Blessing JA, Gershenson DM and McGehee R: Paclitaxel and Cisplatin as First-Line Therapy in Recurrent or Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study. J Clin Oncol 17: 2676, 1999.
18. Alcindor T: Activity of paclitaxel in metastatic squamous anal carcinoma. Int J Colorectal Dis 23: 717, 2008.
19. Hussain M, Gadgeel S, Kucuk O, Du W, Salwen W and Ensley J: Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck. Cancer 86: 2364-2369, 1999. (Pubitemid 30010379)
20. Moosmann P, Egli F, Stahel RA and Jost L: Weekly paclitaxel and carboplatin combination chemotherapy in patients with advanced squamous cell carcinoma of the head and neck. Onkologie 26: 568-572, 2003. (Pubitemid 38056744)
21. McGuire WP, Blessing JA, Moore D, Lentz SS and Photopulos G: Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol 14: 792-795, 1996. (Pubitemid 26085522)
22. Ferrari D, Fiore J, Codecà C, Di Maria G, Bozzoni S, Bordin V, Caldiera S, Luciani A, Zonato S, Floriani I and Foa P: A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer. Anticancer Drugs 20: 185-190, 2009.
23. Basaran M, Bavbek SE, Güllü I, Demirelli F, Sakar B, Tenekeci N, Altun M, Yalçin S and Onat H: A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer. J Chemother 14: 207-213, 2002. (Pubitemid 34454637)